Articles that mention AstraZeneca -BoardProspects

AstraZeneca

0 Comments Leave a Comment

1-15 of 23 1 2 »
1. Mentioned In 23 Articles
2. AstraZeneca Plots Search for Next Chairman
  
  Explore Yahoo! UK & Ireland Finance Jun 3 2019 BoardNews
  
  ... stages of planning to seek an eventual replacement for Leif Johansson, who has chaired AZ for seven years... AstraZeneca (AZ), the FTSE-100 pharmaceuticals group, is preparing a search for the successor to the chairman ...
  Read Full Article
  
  Comment
  
  Mentions: Takeover Bid Succession CFO
3. Exploring Employee Activism: Why This Stakeholder Group Can No Longer Be Ignored
  
  Explore greenbiz.com May 27 2019 BoardBlogs
  
  ...ore values can bring a powerful competitive advantage. Jim Massey, global vice president of sustainability at AstraZeneca, told me he sees a pressing need for greater inclusion: "The societal challenges we are facing tod...
  Read Full Article
  
  Comment
  
  Mentions: Management Amazon ISS
4. Proteostasis Therapeutics Appoints Dr. Badrul Chowdhury, Former FDA Director of Pulmonology, to Board of Directors
  
  Explore gurufocus.com May 13 2019 BoardMoves
  
  ...ne for more than a decade and has more than two decades of regulatory leadership experience. Prior to joining AstraZeneca in April 2018, Dr. Chowdhury served at the FDA for 21 years, where he held numerous leadership rol...
  Read Full Article
  
  Comment
  
  Mentions: SEC Canada AstraZeneca
5. Could Proxy Advisers Sway Investors to Vote ‘No’ on BMS-Celgene Merger?
  
  Explore Pharma News Mar 21 2019 BoardBlogs
  
  ...rms like ISS certainly can’t be discounted when it comes to swaying shareholder opinion. Last year, ISS urged AstraZeneca shareholders to vote against the company’s planned bonus for CEO Pascal Soriot. That was enough to...
  Read Full Article
  
  Comment
  
  Mentions: Management Investors Credit Suisse
6. Lilly CEO David Ricks Snags $17.2M Pay Package for 2018, a 9% Hike
  
  Explore Pharma News Mar 13 2019 BoardNews
  
  ...hrough some problems of its own, paid its helmsman Olivier Brandicourt $8.2 million last year, a 25% decline. AstraZeneca CEO Pascal Soriot's pay climbed to nearly $15 million, and new Novartis helmsman Vas Narasimhan ea...
  Read Full Article
  
  Comment
  
  Mentions: Sanofi stock options David Ricks
7. AstraZeneca Pays CEO Soriot Nearly $15M After 2018's Return to Growth. Will Investors Push Back?
  
  Explore Pharma News Mar 5 2019 BoardNews
  
  ...AstraZeneca CEO Pascal Soriot earned 11.36 million in total pay last year, a 9% increase over 2017. (AstraZeneca) In the past, AstraZeneca's investors have hit out at the company for executive compensation they ...
  Read Full Article
  
  Comment
  
  Mentions: Executive Compensation Investors stock options
8. AVEO Oncology Announces Appointment of Gregory T. Mayes to its Board of Directors
  
  Explore businesswire.com Feb 26 2019 BoardMoves
  
  ...range of legal services in connection with the development and commercialization of five approved products in AstraZeneca's oncology portfolio. Mayes is a cum laude graduate of Syracuse University where he was recognized...
  Read Full Article
  
  Comment
  
  Mentions: Management SEC Compliance
9. Kimberly-Clark Elects Sheri McCoy to its Board of Directors
  
  Explore gurufocus.com Sep 12 2018 BoardMoves
  
  ...s, a personal care products company, until retiring earlier this year. Ms. McCoy also serves on the boards of AstraZeneca PLC, Certara, Novocure, Stryker Corp., Catalyst and Stonehill College. She holds a Bachelor of Sci...
  Read Full Article
  
  Comment
  
  Mentions: Twitter Facebook Kimberly-Clark
10. Lehman Brothers Collapse: Where Are The Key Figures Now?
  
  Explore Yahoo! UK & Ireland Finance Sep 11 2018 BoardNews
  
  ...he City. As well as chairing Santander’s UK business she is a director of FTSE 100 companies BHP Billiton and AstraZeneca and has other advisory roles. Vadera, who is 56, has been mentioned as a possible successor to Mar...
  Read Full Article
  
  Comment
  
  Mentions: Credit Suisse Citigroup Goldman Sachs
11. U.K. Firms Must Justify Executive Pay Gaps Under Government Plan
  
  Explore BNN Bloomberg Jun 9 2018 BoardNews
  
  ...il giant Royal Dutch Shell Plc, industrial takeover specialist Melrose Industries Plc and pharmaceutical firm AstraZeneca Plc have also faced opposition to pay plans for their bosses. “Most of the U.K.’s largest companie...
  Read Full Article
  
  Comment
  
  Mentions: Bloomberg stock options Shell
12. ArunA Biomedical Appoints Industry Veteran Skip Irving to Board of Directors
  
  Explore businesswire.com May 31 2018 BoardMoves
  
  ...ular therapy company that was sold to Perkin Elmer. He also worked in manufacturing and quality assurance for AstraZeneca plc. Today, Skip serves as Vice Chairman of the Board of Directors of the Michael J. Fox Foundatio...
  Read Full Article
  
  Comment
  
  Mentions: acquisition MBA Sky
13. Despite 34% Cut, AstraZeneca Shareholders Still Don't Like CEO Soriot's £9.4M Pay
  
  Explore Pharma News May 21 2018 BoardNews
  
  ...ear, with 35% having voted against it, including the 9.4 million package for CEO Pascal Soriot. (AstraZeneca) AstraZeneca has made some headway with investors persistently provoked by its executive paybut not much... Ast...
  Read Full Article
  
  Comment
  
  Mentions: Executive Compensation Investors hostile takeover
14. It's Another Dust-Up Over AstraZeneca's CEO Pay, This Time Focused on His Bonus
  
  Explore Pharma News May 8 2018 BoardBlogs
  
  ...executives promise light at the end of the tunnel The question is, will shareholders be satisfied enough with AstraZeneca’s performance to wave through Soriot’s big bonus at the company’s annual meeting on May 18? The co...
  Read Full Article
  
  Comment
  
  Mentions: Executive Compensation Corporate Governance ISS
15. Stephen Berenson Joins Moderna's Board of Directors
  
  Explore businesswire.com Oct 10 2017 BoardNews
  
  ...c partners. Headquartered in Cambridge, Mass., privately held Moderna currently has strategic agreements with AstraZeneca, Merck and Vertex Pharmaceuticals, as well as the Defense Advanced Research Projects Agency (DARPA...
  Read Full Article
  
  Comment
  
  Mentions: Board of Trustees Investment Management
16. Uber’s Chaos is a Great Argument for Going Public Quickly
  
  Explore MarketWatch Aug 30 2017 BoardBlogs
  
  ... is paying to buy Monsanto , one of the largest chemical companies in the world. It is more than the value of AstraZeneca , one of the world’s largest drug manufacturers. Sure, Uber is a private company. But with the vas...
  Read Full Article
  
  Comment
  
  Mentions: IPO Theranos Uber
17. 1-15 of 23 1 2 »